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Management of a patient with an open abdomen is difficult, and the primary closure 
of the fascial edges is essential to obtain the best patient outcome, regardless of the 
initial etiology of the open abdomen. The use of temporary abdominal closure devices 
is nowadays the gold standard to have the highest closure rates with mesh-mediated 
fascial traction as the proposed standard of care. However, the incidence of incisional 
hernias, although much more controlled than when leaving an abdomen open, is high 
and reaches up to 65%. As shown for other high-risk patient subgroups, such as obese 
patients, patients with an abdominal aneurysm, and patients with former -ostomy sites, 
the prevention of incisional hernias might be key to further optimize patient outcomes 
after open abdomen treatment. In this overview, current available modalities to decrease 
the incidence of incisional hernia are discussed. Most of these preventive options have 
been shown effective in giant ventral hernia repair and might work effectively in this 
patient cohort with open abdomen as well.
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inTRODUCTiOn
Open abdomen therapy is sometimes necessary to save lives in trauma and nontrauma surgical 
indications (1). Different reasons might be the underlying cause for the choice of the surgeon to 
leave the abdominal cavity open: visceral edema and inability to close the fascial edges, fear for 
intraabdominal hypertension and abdominal compartment syndrome, a planned relaparotomy or 
sepsis with the need for intraabdominal negative pressure therapy.
Management of the open abdomen in the postoperative phase is difficult, because of fluid shifts, 
loss of domain, and the underlying metabolic derangements. Complications associated with the 
open abdomen technique also have been reported, with the development of entero-atmospheric 
fistulas and infectious complications in this severely ill patient population. One can postulate that 
patients who require open abdomen management are at a substantial risk for systemic infectious 
complications, because of the use of temporary abdominal closure (TAC) techniques, a prolonged 
inflammatory phase, and the acquired immunocompromised state. These extraabdominal second-
ary infectious complications may play a considerable role in whether primary closure is achieved 
(2). The high burden of comorbidities and the severe illness of these patients may also lead to the 
prolongation of open abdomen therapy and more difficulties to finally close the abdominal cavity.
Nowadays, different TAC techniques are frequently used, and a real consensus on which technique 
to be used has not yet been reached (3, 4). The TAC dressing should ideally cover the intraabdominal 
contents to maintain a physiological environment in an active way, prevent evisceration, prevent 
adhesions, protect the bowel wall from injury, remove the excess of wound fluid, bacteria, and 
cytokines in an active way, and should also facilitate subsequent abdominal wall closure as early as 
possible, preferably within 2 weeks.
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The “old-classic” Bogota bag, a silastic or a silicon sheet, just a 
skin approximation or a zipper-type of closure, might be valuable 
in cases with damage control surgery and intraabdominal bleed-
ing, in which definitive closure is anticipated within the next 2 
or 3 days. No fluid removal is possible, and as there is no fascial 
traction present, these devices should not be left in place for more 
than 3–4 days.
A Wittmann Patch, dynamic retention sutures, or inlay mesh 
placement are examples of a more dynamic closure technique, 
which can be used as a temporary TAC system to prevent lat-
eral fascial retraction and permit adjustments according to the 
intraabdominal pressure. They facilitate reoperation, but do not 
allow for the effective drainage of intraabdominal fluids and 
bacteria. Furthermore, they might be related to an increased rate 
of enterocutaneous fistula (5). In addition, there is a concern that 
the sutures placed on the fascia might cause ischemic damage to 
the edges, making the definitive closure more difficult.
In case of an infected or contaminated abdominal cavity, 
intraabdominal negative pressure treatment plays an important 
role: it is able to remove peritoneal fluid and inflammatory media-
tors, reduces the concentration of cytokines in the bloodstream, 
and partially facilitates the approximation of the fascial edges. 
Among the different NPT techniques (Barker vacuum pack, VAC 
abdominal dressing system™, and ABThera™), the ABThera 
dressing system seems to achieve better results in terms of sur-
vival, enterocutaneous fistula rate, and peritoneal fluid removal 
(6). However, attention has to be paid to incomplete hemostasis 
and high-risk gastrointestinal anastomoses. Dressing chances are 
performed every 1–3 days or even more frequently in case there 
is an abdominal contamination or an infection. Moreover, the 
combination of both negative pressure therapy and fascial trac-
tion has been demonstrated to be ideal in managing patients who 
may not achieve primary facial closure with intraabdominal NPT 
alone (7, 8). A definitive closure can then be obtained only when 
the abdominal acute condition and bowel edema are resolved and 
the intraabdominal pressure remains under 25–30 mmHg (3).
OPen ABDOMen CLOSURe
In case patients have been treated adequately for an open abdo-
men, the final closure of the abdomen should be achieved within 
10–14 days after the initial surgery. However, the evidence on how 
to perform an optimal fascial closure in these patients is scarcely 
documented. Only three observational cohort studies described 
the fascial closure method for both septic and non-septic patient 
conditions, but no data were available on, e.g., burst abdomen 
or fistula formation (9–11). In these studies, both continuous 
and interrupted suture techniques were used, but there is a high 
heterogeneity among these studies as it concerns case series only. 
Sörelius et al. reported on 30 patients treated with OA among a 
cohort of 1,041 patients treated for an aortic aneurysm (9). Four 
died before abdominal closure, while primary delayed fascial 
closure was achieved in all survivors. Incisional hernias occurred 
in 9 of 15 patients (60%); only three were symptomatic. They used 
mesh-mediated fascial traction, and at the time of final closure, 
the entire mesh was removed and the fascia was closed with a 
running 0 polydioxanone suture, by means of a standardized 
suturing technique aiming at a suture length to wound length 
ratio of at least 4:1. By contrast, Brandl et al. published their cohort 
of 209 OA patients in which the final fascial closure technique 
was determined by the surgeon in charge and recorded as con-
tinuous or interrupted, using absorbable or nonabsorbable suture 
materials (10). In case of continuous suturing, they followed the 
4:1 ratio rule. In a few patients (7.3%) in which direct fascial 
closure was not possible, they used a biological or a synthetic 
mesh to bridge the defect. In their analysis, they showed a trend 
toward a higher incisional hernia rate for the interrupted rapidly 
absorbable sutures (41 versus 10% for rapidly absorbable and 
slowly resorbable sutures, respectively). In another cohort of 87 
patients reported by Fortelny et al., dynamic fascial sutures were 
combined with negative pressure therapy; closure was achieved 
in 78% of patients after 12.6  days and 4.3 reoperations (11). 
Fifty-five patients (63.2%) were closed using a non-resorbable 
or slowly resorbable running suture, while eight patients (9.2%) 
had an interrupted suturing technique. No further details on the 
outcomes regarding the different suturing technique and materi-
als were reported in this study.
Regarding fascial closure, also other reconstructive techniques 
have been described, using different flap reconstructions as the 
bipedicled myofascial oblique rectus abdominis flap and the bilat-
eral anterior rectus abdominis sheath turnover flap. However, 
besides the surgical technique, very limited long-term data have 
been reported regarding both complication and incisional hernia 
rates (12, 13).
Therefore, according to the limited data available and no 
formal consensus in the literature, a continuous fascial closure 
seems most logical, in accordance with the guidelines of the 
European Hernia Society on abdominal wall closure, using slowly 
resorbable sutures in a suture to wound length ratio of 4:1 as 
initially described by Israellson and coworkers (14, 15).
inCiDenCe OF inCiSiOnAL HeRniA 
AFTeR OPen ABDOMen TReATMenT
Despite all efforts to finally obtain full fascial closure in OA 
patients, the long-term follow-up of these patients in terms of 
incisional hernia rate is scarce, but rather worrisome. Again, 
only three studies reported on long-term outcome data, two of 
which were prospective (16–18). The total number of patients 
is low (range 14–50), and the incidence of incisional hernias 
ranged from 21% at 21 months to 54% after 5 years of follow-up. 
The repair rate differed and was 33 and 42% in the prospective 
cohorts, respectively.
Bjarnason and coworkers reported their 1-year follow-up after 
a mesh-mediated fascial closure in combination with NPT and 
described 66% of incisional hernias in these patients using CT 
evaluation (19). Remarkably, four patients who had early defini-
tive fascial closure with permanent mesh reinforcement did not 
show an incisional hernia. Suturing of the mesh to the fascial 
edges as in the mesh-mediated fascia traction method may lead 
to incisional hernia development, due to possible greater traction 
on the fascial edges. Therefore, despite the fact that more patients 
can be closed after OA treatment and TAC therapy using fascial 
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traction in combination with NPT, the focus for these patients 
should now more and more be on how to prevent incisional 
hernias from developing after final fascial closure in this patient 
population.
PRevenTiOn OF inCiSiOnAL HeRniA 
DeveLOPMenT AFTeR OA 
MAnAGeMenT
In general, the prevention of incisional hernia can be achieved 
using a state-of-the-art suturing technique with an SL:WL ratio 
of 4:1 or more, using small bites instead of large ones on both 
fascial edges, limiting traction on the fascial edges at the time of 
the final fascial closure and by using a mesh at the time of closure. 
If this is true for different patient settings as patients with paras-
tomal hernias, midline laparotomy closure in high-risk patients 
with previous ostomies, AAA patients, and obese patients, the 
same could be true for the high-risk patient population that OA 
patients resemble. However, as OA patients are mostly severely ill, 
malnourished, and on top of that, the fascial edges are generally 
more fragile due to previous OA treatment, the usage of a correct 
surgical technique with adequate length ratio, and small bites 
might not be sufficient in these patients, as is shown by the high 
rates of incisional formation in these patients. Therefore, other 
available surgical techniques in abdominal wall reconstruction 
might be appropriate to apply in OA fascial closure. The main 
objective should probably be the release of tension on the fascial 
edges to allow for a “tension-free” closure of the fascia. Different 
options will be discussed here, although evidence on these tech-
niques for this specific indication is almost nonexisting.
Component Separation Techniques (CSTs)
Component separation technique is nowadays a well-known 
surgical technique, with multiple anatomical variants (20, 21). 
It will allow for the medial advancement of the fascia edges up 
to 10  cm on each side around the umbilicus, so that defects 
up to 15–20  cm in width can be closed with an augmentation 
technique. Therefore, in OA patients, this technique can be con-
sidered as a useful adjunct to achieve the final fascial closure. Two 
observational studies using CST and two observational studies 
using other fascio-myoplasty techniques could be retrieved from 
the literature (12, 22, 23). However, these reports document only 
on these techniques with an indication to close the fascial edges at 
the time of final closure and not in relation to prophylaxis. For the 
flap techniques, only Kushimoto reported on long-term data in 
these patients with half of the patients showing a mid-abdominal 
bulging but no incisional hernias in 10 patients after a 65-month 
follow-up without further specification (12). The same is true for 
the papers reporting on CST for OA patients. Rasilainen et  al. 
published on 16 patients of which 9 patients were treated using 
CST at the time of final fascial closure and 7 during ongoing open 
abdomen management (23). All patients with CST at the time 
of final closure could be primarily closed. Out of eight patients 
who survived and had CST at the time of fascial closure, 25% 
developed an incisional hernia. Sriussadapron et al. also reported 
on eight patients who had closure of “acute abdominal wall 
defects” using CST, but using various modifications of the CST, 
making comparison difficult (22). No report on incisional hernia 
development in these patients was done. Despite these very low 
numbers, a recent review by Sharrock et al. stated that the use 
of CST may be a valid alternative to delayed primary closure 
following damage control laparotomy in trauma patients (24). 
Regarding the combination of CST and mesh augmentation, 
there is no evidence supporting this; however, when considering 
the results of CST only in large incisional hernia repair, which are 
rather poor (25), a combination of CST and mesh augmentation 
might be an option.
In the study by Bjarnason et al., eight patients had early fascial 
closure with synthetic mesh reinforcement, of which four survi-
vors showed no incisional hernia later on, but again, this synthetic 
mesh was only used to get the abdominal wall closed and not 
as “additional prophylaxis” (19). Based on this evidence, it is 
still very much unclear whether CST should be advocated to be 
used preventively, in addition to primary fascial closure in order 
to release tension and decrease incisional hernia development. 
Furthermore, the use of CST in these patients will burn a pos-
sible “bridge” for later complex hernia repair in case an incisional 
hernia will develop. It is clear that more data and well-designed 
studies are needed to clarify the role of CST as a preventive tool 
in OA patients.
Use of Botulinum Toxin Type A (BTA)
As proven methods for decreasing the rate of planned ventral 
hernia provide tension in the midline to counter the effects of 
lateral abdominal wall muscular retraction (26–28), BTA is an 
FDA-approved neuromodulating agent that has now become 
increasingly popular in abdominal wall reconstruction (29, 30). 
This toxin functions by blocking the release of acetylcholine and 
pain modulators and is also referred to as a “chemical compo-
nents separation” technique, which takes advantage of the flaccid 
paralysis created after BTX injection. If this flaccid paralysis can 
provide decreased midline abdominal wall tension, then, theo-
retically, the rate of primary fascial closure will increase, or as 
meant in prevention, the number of incisional hernias after OA 
treatment might decrease.
The only report involving BTX in open abdomen management 
has been published by Zielinski et al. (31). They recommend the 
use of either a negative pressure dressing or a Wittmann Patch 
as a TAC device at the time of the initial laparotomy, to ensure 
midline tension. After stabilization of the patient, at the time 
of reexploration or changing the NPT dressing, the patient can 
be prepared to allow for sufficient space for ultrasound-guided 
BTX injection. Three-hundred units of BTX are reconstituted in 
150 cc of injectable normal saline and injected according to the 
protocol as described by Zendejas et al. (32). They reported on 18 
patients for who the primary fascial closure rate was 83%. Nine 
patients underwent chemical components separation within 
24 h of their initial OA procedure. Of these, 89% (8/9) achieved 
primary fascial closure, without complications related to BTX. 
The presence of an open abdomen allows for biomechanical 
forces to develop that ordinarily are counteracted from the 
normal anatomical structure of the abdominal wall. The lateral 
abdominal wall musculature (external oblique, internal oblique, 
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and transversus abdominus) creates a lateral retraction force that 
is opposed centrally at the linea alba. The success of negative pres-
sure dressings and the Wittmann Patch in enhancing the ability to 
perform primary fascial closure is likely related to the opposition 
of this lateral wall abdominal retraction. Logically, therefore, if a 
safe method of decreasing the lateral abdominal wall retraction 
can be developed, the ability to perform primary fascial closure 
could improve. But again, no data are available on using BTX as 
a preventive measure, for example, at the time of final primary 
closure to explore the benefit of this decreased tension at the level 
of the linea alba in terms of incisional hernia development.
Mesh
Regarding the closure of an open abdomen, both the synthetic 
mesh-mediated fascial traction in combination with NPT has 
been advocated, with currently the best outcomes reported, as 
well as the use of (resorbable) meshes as an adjunct to primary 
fascial closure during OA management. Four observational 
studies (33–36) reported on using mesh at the time of primary 
fascial closure. Regarding the presence of an incisional hernia, all 
together, 98 patients were studied with an incidence of incisional 
hernias of around 20%. It is clear that the surgical site occurrences 
and infection rate are increased when using mesh (up to 30%). 
Therefore, there is very limited evidence that supports the use of 
mesh reinforcement after fascial closure in an OA. On the other 
hand, in comparison, again, with other high-risk population 
for the development of incisional hernias, it seems logical to 
extrapolate these data to the OA population in order to decrease 
the percentage of incisional hernias. There is absolutely no data 
to propose a certain position of the mesh, i.e., onlay, sublay, or 
intraperitoneal mesh positioning. However, looking at the techni-
cal difficulty, the risk for mesh infection, and comparing different 
other indications for prophylactic mesh use, the use of a mesh in 
an onlay position seems appropriate (37). As it is also not clear 
up to now, whether we might need definitive or temporary mesh 
reinforcement after primary fascial closure in these patients, the 
type of mesh, synthetic, biological, or biosynthetic (or a hybrid 
or a long-term resorbable synthetic), is not known and cannot 
be recommended at this point of time. When considering the 
higher percentage of SSO and SSI when using mesh, this might 
be a reason for surgeons to choose for a biological or long-term 
resorbable synthetic mesh (TIGR™, Bio-A™, or Phasix™). On 
the other hand, as the incidences of SSO reported in the trials 
for parastomal mesh prevention are so low (38), a permanent 
synthetic mesh might work well and might give the best results 
on the long term, regarding incisional hernia rates.
COnCLUSiOn
Considering the OA patient population, abdominal wall closure 
is our main priority, and the use of TAC techniques seems 
advocated to using a combination of (dynamic) fascial traction 
and NPT. However, as the rate of incisional hernia formation is 
extremely high among survivors in this group of patients, preven-
tion at the time of fascial closure seems mandatory as well as 
logical. As the proposed surgical techniques for closure of the 
abdominal wall, as proposed by the EHS, do not really apply to this 
subset of patients with an open abdomen, mesh reinforcement, 
CSTs, and the use of BTA might have their place in prevention. 
However, as the literature on this specific issue is lacking, only 
data extrapolation from other high-risk groups seems possible, 
with all its inherent limitations. No definitive conclusions can 
be made regarding their use in terms of prevention of incisional 
hernia development at the time of primary fascial closure in open 
abdomen patients. More future studies, together with register 
data, have to tackle this issue and could help us to further refine 
open abdomen management.
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